ACIU — AC Immune SA Share News
0.000.00%
Last trade - 00:00- $260.54m
- $173.47m
- CH₣3.57m
AC Immune SA expected to post a loss of 17 rappen a share - Earnings Preview
Brief: AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Brief: AC Immune SA - ACI-7104.056 Is Well Tolerated With No Safety Issues Reported To Date
AC Immune SA reports results for the quarter ended December 31 - Earnings Summary
AC Immune SA expected to post a loss of 19 rappen a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Talen Energy, Biogen, Ovintiv
U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, Sonos
U.S. STOCKS ON THE MOVE-Walt Disney, Hilton, Oklo
AC Immune rises on interim mid-stage data for Parkinson's therapy
Brief: AC Immune Reports Positive Interim Results From Phase 2 Trial Of ACI-7104.056
AC Immune SA reports results for the quarter ended in September 30 - Earnings Summary
AC Immune SA expected to post a loss of 20 rappen a share - Earnings Preview
Brief: Ac Immune’S Pi-2620 Tau-Pet Diagnostic In Phase 3 Receives Fast Track Designation
Brief: AC Immune SA Says May Offer And Sell Common Shares Of Up To $80 Million From Time To Time
AC Immune SA reports results for the quarter ended in June - Earnings Summary
Swiss stocks - Factors to watch on August 5
Swiss stocks - Factors to watch on August 2
AC Immune SA expected to post earnings of 27 rappen a share - Earnings Preview
Brief: Ac Immune’S Aci-35.030 (Now “JNJ-2056”) Granted FDA Fast Track Designation For Alzheimer’S Disease